First Wave BioPharma Names Brian Feagan, M.D., to Scientific Advisory Board
09.12.2021 - Appointment of world-renowned gastroenterologist and researcher reflects expanded clinical development of niclosamide in the treatment of inflammatory bowel diseases (IBDs)BOCA RATON, Fla., Dec. 09, 2021 (GLOBE NEWSWIRE) - First Wave BioPharma, ... Seite 1
Richard Marlink Michael Konstan Anthony Opipari James Sapirstein First Wave Biopharma Wave Biopharma
Source: wallstreet-online.de